Close
  Indian J Med Microbiol
 

Table 5: Cox model for hazard of exacerbation over 23,473 periods of follow-up under a double therapy with corticoid treatment with 4,633 COPD exacerbations identified. Adjusted for age, sex, number of exacerbations during the previous year, changes in treatment during the previous year, diabetes, dyslipidemia, ischemic heart disease, obstructive sleep apnea syndrome, chronic kidney disease, chronic hepatopathy and hypertension

Table 5: Cox model for hazard of exacerbation over 23,473 periods of follow-up under a double therapy with corticoid treatment with 4,633 COPD exacerbations identified. Adjusted for age, sex, number of exacerbations during the previous year, changes in treatment during the previous year, diabetes, dyslipidemia, ischemic heart disease, obstructive sleep apnea syndrome, chronic kidney disease, chronic hepatopathy and hypertension